Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith C Ferdinand

Showing results (191-200 of 287) with videos related to

Pageof 29
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|December 22, 2009
Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial functionNadya Merchant, Charles D Searles, Anbu Pandian, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 13, 2009
Amlodipine/Atorvastatin single-pill therapy for blood pressure and lipid goals in African Americans: influence of the metabolic syndrome and type 2 diabetes mellitusKeith C Ferdinand, John M Flack, Elijah Saunders, et al.
The American Journal of Cardiology|September 16, 2018
Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic HypertensionKeith C Ferdinand, George L Bakris, William C Cushman, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 11, 2008
Hypertensive urgencies in the emergency department: evaluating blood pressure response to rest and to antihypertensive drugs with different profilesDaniel Grassi, Martin O'Flaherty, Marcelo Pellizzari, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 1, 2017
Disparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherenceKeith C Ferdinand, Kapil Yadav, Samar A Nasser, et al.
American Journal of Preventive Cardiology|November 25, 2022
Defining preventive cardiology: A clinical practice statement from the American Society for Preventive CardiologyCharles A German, Seth J Baum, Keith C Ferdinand, et al.
American Heart Journal Plus : Cardiology Research and Practice|September 15, 2023
TEXT MY BP MEDS NOLA: A pilot study of text-messaging and social support to increase hypertension medication adherenceDaphne P Ferdinand, Tina K Reddy, Madeline R Wegener, et al.
Journal of the American College of Cardiology|January 15, 2011
The coalition to reduce racial and ethnic disparities in cardiovascular disease outcomes (credo): why credo matters to cardiologistsClyde W Yancy, Tracy Y Wang, Hector O Ventura, et al.
Clinical Therapeutics|November 9, 2004
Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trialPeter H Jones, Donald B Hunninghake, Keith C Ferdinand, et al.
Cardiorenal Medicine|January 30, 2014
Changes in Central Aortic Pressure, Endothelial Function and Biomarkers in Hypertensive African-Americans with the Cardiometabolic Syndrome: Comparison of Amlodipine/Olmesartan versus Hydrochlorothiazide/LosartanBobby V Khan, Nadya Merchant, Syed T Rahman, et al.
Pageof 29

Showing results (191-200 of 287) with videos related to

Sort By:
Pageof 29
Journal of Clinical Hypertension (Greenwich, Conn.)|December 22, 2009
Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial functionNadya Merchant, Charles D Searles, Anbu Pandian, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 13, 2009
Amlodipine/Atorvastatin single-pill therapy for blood pressure and lipid goals in African Americans: influence of the metabolic syndrome and type 2 diabetes mellitusKeith C Ferdinand, John M Flack, Elijah Saunders, et al.
The American Journal of Cardiology|September 16, 2018
Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic HypertensionKeith C Ferdinand, George L Bakris, William C Cushman, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 11, 2008
Hypertensive urgencies in the emergency department: evaluating blood pressure response to rest and to antihypertensive drugs with different profilesDaniel Grassi, Martin O'Flaherty, Marcelo Pellizzari, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 1, 2017
Disparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherenceKeith C Ferdinand, Kapil Yadav, Samar A Nasser, et al.
American Journal of Preventive Cardiology|November 25, 2022
Defining preventive cardiology: A clinical practice statement from the American Society for Preventive CardiologyCharles A German, Seth J Baum, Keith C Ferdinand, et al.
American Heart Journal Plus : Cardiology Research and Practice|September 15, 2023
TEXT MY BP MEDS NOLA: A pilot study of text-messaging and social support to increase hypertension medication adherenceDaphne P Ferdinand, Tina K Reddy, Madeline R Wegener, et al.
Journal of the American College of Cardiology|January 15, 2011
The coalition to reduce racial and ethnic disparities in cardiovascular disease outcomes (credo): why credo matters to cardiologistsClyde W Yancy, Tracy Y Wang, Hector O Ventura, et al.
Clinical Therapeutics|November 9, 2004
Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trialPeter H Jones, Donald B Hunninghake, Keith C Ferdinand, et al.
Cardiorenal Medicine|January 30, 2014
Changes in Central Aortic Pressure, Endothelial Function and Biomarkers in Hypertensive African-Americans with the Cardiometabolic Syndrome: Comparison of Amlodipine/Olmesartan versus Hydrochlorothiazide/LosartanBobby V Khan, Nadya Merchant, Syed T Rahman, et al.
Pageof 29